earnings
confidence high
sentiment positive
materiality 0.80
Turning Point Brands Q2 net sales up 25% to $116.6M; Modern Oral surges 651%; raises guidance
Turning Point Brands, Inc.
2025-Q2 EPS reported
$1.58
revenue$223,070,000
- Net sales $116.6M (+25.1% YoY); net income $14.5M (+11.3%); diluted EPS $0.79.
- Modern Oral sales $30.1M (+651% YoY), now 26% of total sales; Stoker's segment up 62.9%.
- Adjusted EBITDA $30.5M (+14.8%); adjusted diluted EPS $0.98 vs $0.89 prior year.
- Raises 2025 Adj. EBITDA guidance to $110-114M (from $108-113M).
- Raises 2025 Modern Oral sales guidance to $100-110M (from $80-95M).